Aegerion To Plead Guilty, Pay $40M To Settle Justice, SEC Investigations
CAMBRIDGE, Mass. — Aegerion Pharmaceuticals Inc. on May 12 said in a press release that it will plead guilty to federal misdemeanor violations and pay about $40 million to settle investigations...To view the full article, register now.
Already a subscriber? Click here to view full article